Ethical and scientific issues in studying the safety of approved drugs / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Year of Publication:2012
Language:English
Online Access:
Physical Description:xvi, 275 p. :; ill.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5003564274
ctrlnum (MiAaPQ)5003564274
(Au-PeEL)EBL3564274
(CaPaEBR)ebr10606354
(CaONFJC)MIL394890
(OCoLC)811594850
collection bib_alma
record_format marc
spelling Ethical and scientific issues in studying the safety of approved drugs [electronic resource] / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
Washington, D.C. : National Academies Press, c2012.
xvi, 275 p. : ill.
Includes bibliographical references.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Drugs Testing Moral and ethical aspects United States.
Clinical trials Moral and ethical aspects United States.
Drug approval United States.
Electronic books.
Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice.
National Academies Press (U.S.)
ProQuest (Firm)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564274 Click to View
language English
format Electronic
eBook
author2 Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice.
National Academies Press (U.S.)
ProQuest (Firm)
author_facet Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice.
National Academies Press (U.S.)
ProQuest (Firm)
Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice.
National Academies Press (U.S.)
ProQuest (Firm)
author2_role TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
author_corporate Institute of Medicine (U.S.). Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.
Institute of Medicine (U.S.). Board on Population Health and Public Health Practice.
National Academies Press (U.S.)
ProQuest (Firm)
title Ethical and scientific issues in studying the safety of approved drugs
spellingShingle Ethical and scientific issues in studying the safety of approved drugs
title_full Ethical and scientific issues in studying the safety of approved drugs [electronic resource] / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
title_fullStr Ethical and scientific issues in studying the safety of approved drugs [electronic resource] / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
title_full_unstemmed Ethical and scientific issues in studying the safety of approved drugs [electronic resource] / Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.
title_auth Ethical and scientific issues in studying the safety of approved drugs
title_new Ethical and scientific issues in studying the safety of approved drugs
title_sort ethical and scientific issues in studying the safety of approved drugs
publisher National Academies Press,
publishDate 2012
physical xvi, 275 p. : ill.
callnumber-first R - Medicine
callnumber-subject RM - Therapeutics and Pharmacology
callnumber-label RM301
callnumber-sort RM 3301.27 E84 42012
genre Electronic books.
genre_facet Electronic books.
geographic_facet United States.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564274
illustrated Illustrated
oclc_num 811594850
work_keys_str_mv AT instituteofmedicineuscommitteeonethicalandscientificissuesinstudyingthesafetyofapproveddrugs ethicalandscientificissuesinstudyingthesafetyofapproveddrugs
AT instituteofmedicineusboardonpopulationhealthandpublichealthpractice ethicalandscientificissuesinstudyingthesafetyofapproveddrugs
AT nationalacademiespressus ethicalandscientificissuesinstudyingthesafetyofapproveddrugs
AT proquestfirm ethicalandscientificissuesinstudyingthesafetyofapproveddrugs
status_str n
ids_txt_mv (MiAaPQ)5003564274
(Au-PeEL)EBL3564274
(CaPaEBR)ebr10606354
(CaONFJC)MIL394890
(OCoLC)811594850
is_hierarchy_title Ethical and scientific issues in studying the safety of approved drugs
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
noLinkedField
_version_ 1792330884987224064
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01815nam a2200385Ia 4500</leader><controlfield tag="001">5003564274</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">120529s2012 dcua sb 000 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2012021854</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309218139</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780309218146</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5003564274</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL3564274</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10606354</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL394890</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)811594850</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM301.27</subfield><subfield code="b">.E84 2012</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Ethical and scientific issues in studying the safety of approved drugs</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">c2012.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xvi, 275 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Testing</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical trials</subfield><subfield code="x">Moral and ethical aspects</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug approval</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Board on Population Health and Public Health Practice.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Academies Press (U.S.)</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=3564274</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>